Saudi German Hospital Jeddah Successfully Performs 12th Liver Transplant Surgery
Jeddah – 
:
Saudi German Hospital Jeddah announced its 12th successful liver transplant surgery on a 58-year-old mother whose liver was extremely damaged with an abnormally large amount of scar tissue. The son of the patient, whose liver was found to be a compatible match, donated 60 per cent of his liver to his mother. The surgery, which took approximately 13 hours to be completed, was performed by one of the most prominent Liver Transplant Surgeons in the Middle East, Head of the Liver Transplant Unit at Saudi German Hospital Jeddah, Prof. Dr. Amr Abdel-Aal.
The hospital’s liver transplant surgery department is the only medical facility of its kind in the Western region of the Kingdom of Saudi Arabia and the first and only private hospital in the Kingdom of Saudi Arabia that is able to perform liver transplant surgeries that can treat and address this medical condition. The department is equipped with advanced medical technology and supporting the unit it is a highly experienced and qualified world-class team of medical experts and professionals.
“Saudi German Hospital Jeddah is glad to report that we have successfully administered 12 liver transplants on various patients, including children that needed immediate care and relief. Our medical facilities are managed by highly skilled and trained medical professionals and equipped with the most advanced medical equipment. We are fully committed to provide our patients with the best treatment possible, giving them a chance to live a normal and healthy life,” concluded Prof. Amr Abdel-Aal, Head of the Liver Transplant Unit, Saudi German Hospital Jeddah.
The liver is a vital organ that serves many critical functions, such as the metabolism of drugs and toxins and the removal of products that affect the body’s metabolism. A liver transplant is performed to replace a failing or diseased liver with one that is normal and healthy, where both livers grow back to their original sizes in a few months, for both the recipient and the donor. The treatment option is reserved for people suffering from end-stage chronic liver disease.
